close

MAKO Surgical Corp., a medical device company, provides advanced robotic solution and orthopedic implants for minimally invasive orthopedic knee procedures. It offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient-specific, early to mid-stage osteoarthritic knee disease; and patient specific visualization system that delivers minimally invasive surgical procedures for the knee. The company also provides version 1.0 of the tactile guidance system (TGS) for use with an inlay knee implant system; and version 2.0 of the TGS, which allows orthopedic surgeons to treat degenerative osteoarthritis from early-stage, unicompartmental degeneration through mid-stage, multicompartmental degeneration with a modular knee implant system. In addition, MAKO Surgical Corp. offers The RESTORIS unicompartmental and multicompartmental knee implant systems, which enable an orthopedic surgeon to treat early through mid-stage degenerative osteoarthritis of the knee with a modular implant system. Further, the company provides disposable products, including bone pins and the spheres on the arrays used in the tracking system, irrigation clips and tubes that cool the cutting instruments, drapes to cover the robotic arm, and other items that require disposal after each use. It sells and markets its products through direct sales force and a network of independent orthopedic product agents and distributors in the United States. The company was founded in 1997 and is headquartered in Fort Lauderdale, Florida.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	38.25
Volume	446302
Volume Avg	982503
52 Week High	43.00
52 Week Low	19.51
PE	N/A
PE (group average)	N/A
EPS Year	-0.89
EPS change Q/Q	-3.85%
EPS change Q/Q Yr ago	-20.59%
EPS change Q/Q next Q est	-68.75%
EPS change Y/Y	-14.15%
REV change Q/Q	-12.16%
REV change Q/Q Yr ago	80.56%
EPS next Q est	-0.16
EPS next Y est	-0.13
Divident Annual	0.00
Dividend Yield	0%